Literature DB >> 16542769

Safety evaluation of phytosterol-esters. Part 9: Results of a European post-launch monitoring programme.

L J Lea1, P A Hepburn.   

Abstract

Phytosterol-esters were developed by Unilever as a cholesterol lowering novel food ingredient for use initially in vegetable oil spreads. In addition to an extensive package of safety studies and clinical studies a programme of post-launch monitoring (PLM) was developed. PLM was used to address the following questions: (a) Is the product use as predicted/recommended? (b) Are the known effects as predicted? (c) Does the product cause unexpected health effects? The overall conclusions from the PLM programme were: the product is being bought by the target population but intakes are less than the original assumptions made in the risk assessment; long-term use of phytosterol-ester enriched spreads results in a reduction in the serum levels of the most lipophilic carotenoids but at current levels of intake this is unlikely to result in reductions in carotenoids that are of biological significance; evaluation of health related consumer complaints have not indicated any unexpected health effects associated with the use of the product in the marketplace. As part of the European approval under Regulation (EC) No. 258/97 on Novel Foods and Food Ingredients the results of the PLM programme had to be submitted to the European Commission (EC) and reviewed by the Scientific Committee on Food (SCF). They concluded that the study provided valuable information, which complemented the pre-market safety evaluation studies, and that the EC mandatory requirement had been met.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16542769     DOI: 10.1016/j.fct.2006.01.017

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  5 in total

1.  Functional foods: the case for closer evaluation.

Authors:  Nynke de Jong; Olaf H Klungel; Hans Verhagen; Marion C J Wolfs; Marga C Ocké; Hubert G M Leufkens
Journal:  BMJ       Date:  2007-05-19

Review 2.  The Lipid-lowering Effects and Associated Mechanisms of Dietary Phytosterol Supplementation.

Authors:  Jerad H Dumolt; Todd C Rideout
Journal:  Curr Pharm Des       Date:  2017       Impact factor: 3.116

3.  Dietary phytosterols and phytostanols decrease cholesterol levels but increase blood pressure in WKY inbred rats in the absence of salt-loading.

Authors:  Qixuan Chen; Heidi Gruber; Eleonora Swist; Kara Coville; Catherine Pakenham; Walisundera Mn Ratnayake; Kylie A Scoggan
Journal:  Nutr Metab (Lond)       Date:  2010-02-12       Impact factor: 4.169

4.  Phytosterol oxidation products (POP) in foods with added phytosterols and estimation of their daily intake: A literature review.

Authors:  Yuguang Lin; Diny Knol; Elke A Trautwein
Journal:  Eur J Lipid Sci Technol       Date:  2016-01-21       Impact factor: 2.679

5.  Disruption of Endoplasmic Reticulum and ROS Production in Human Ovarian Cancer by Campesterol.

Authors:  Hyocheol Bae; Sunwoo Park; Changwon Yang; Gwonhwa Song; Whasun Lim
Journal:  Antioxidants (Basel)       Date:  2021-03-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.